Global CRISPR Editing Platform Supply, Demand and Key Producers, 2024-2030

Publication ID:

GIR032417139

Publication Date:

April 9, 2024

Pages:

116

Publisher:

GIR

Countries:

Global [1]

USD 4,480.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global CRISPR Editing Platform market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
The CRISPR Editing Platform is a proprietary cell engineering process that industrializes CRISPR editing to provide superior cell-based models for your disease research.
This report studies the global CRISPR Editing Platform demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for CRISPR Editing Platform, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of CRISPR Editing Platform that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global CRISPR Editing Platform total market, 2019-2030, (USD Million)
Global CRISPR Editing Platform total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: CRISPR Editing Platform total market, key domestic companies and share, (USD Million)
Global CRISPR Editing Platform revenue by player and market share 2019-2024, (USD Million)
Global CRISPR Editing Platform total market by Type, CAGR, 2019-2030, (USD Million)
Global CRISPR Editing Platform total market by Application, CAGR, 2019-2030, (USD Million).
This reports profiles major players in the global CRISPR Editing Platform market based on the following parameters 鈥� company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Synthego, Repare Therapeutics, Crisprqc, Horizon, Crown Bioscience, Editas Medicine, Creative Biogene, Mammoth and Synbio Technologies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CRISPR Editing Platform market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global CRISPR Editing Platform 麻豆原创, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global CRISPR Editing Platform 麻豆原创, Segmentation by Type
Animal Cell Editing Platform
Plant Cell Editing Platform
Global CRISPR Editing Platform 麻豆原创, Segmentation by Application
Gene/Genome Editing
Gene/Genome Screening
Other
Companies Profiled:
Synthego
Repare Therapeutics
Crisprqc
Horizon
Crown Bioscience
Editas Medicine
Creative Biogene
Mammoth
Synbio Technologies
Abace Biology
BRL Medicine Inc
Key Questions Answered
1. How big is the global CRISPR Editing Platform market?
2. What is the demand of the global CRISPR Editing Platform market?
3. What is the year over year growth of the global CRISPR Editing Platform market?
4. What is the total value of the global CRISPR Editing Platform market?
5. Who are the major players in the global CRISPR Editing Platform market?

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 Supply Summary
1.1 CRISPR Editing Platform Introduction
1.2 World CRISPR Editing Platform 麻豆原创 Size & Forecast (2019 & 2023 & 2030)
1.3 World CRISPR Editing Platform Total 麻豆原创 by Region (by Headquarter Location)
1.3.1 World CRISPR Editing Platform 麻豆原创 Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States CRISPR Editing Platform 麻豆原创 Size (2019-2030)
1.3.3 China CRISPR Editing Platform 麻豆原创 Size (2019-2030)
1.3.4 Europe CRISPR Editing Platform 麻豆原创 Size (2019-2030)
1.3.5 Japan CRISPR Editing Platform 麻豆原创 Size (2019-2030)
1.3.6 South Korea CRISPR Editing Platform 麻豆原创 Size (2019-2030)
1.3.7 ASEAN CRISPR Editing Platform 麻豆原创 Size (2019-2030)
1.3.8 India CRISPR Editing Platform 麻豆原创 Size (2019-2030)
1.4 麻豆原创 Drivers, Restraints and Trends
1.4.1 CRISPR Editing Platform 麻豆原创 Drivers
1.4.2 Factors Affecting Demand
1.4.3 CRISPR Editing Platform Major 麻豆原创 Trends
2 Demand Summary
2.1 World CRISPR Editing Platform Consumption Value (2019-2030)
2.2 World CRISPR Editing Platform Consumption Value by Region
2.2.1 World CRISPR Editing Platform Consumption Value by Region (2019-2024)
2.2.2 World CRISPR Editing Platform Consumption Value Forecast by Region (2025-2030)
2.3 United States CRISPR Editing Platform Consumption Value (2019-2030)
2.4 China CRISPR Editing Platform Consumption Value (2019-2030)
2.5 Europe CRISPR Editing Platform Consumption Value (2019-2030)
2.6 Japan CRISPR Editing Platform Consumption Value (2019-2030)
2.7 South Korea CRISPR Editing Platform Consumption Value (2019-2030)
2.8 ASEAN CRISPR Editing Platform Consumption Value (2019-2030)
2.9 India CRISPR Editing Platform Consumption Value (2019-2030)
3 World CRISPR Editing Platform Companies Competitive Analysis
3.1 World CRISPR Editing Platform Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global CRISPR Editing Platform Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for CRISPR Editing Platform in 2023
3.2.3 Global Concentration Ratios (CR8) for CRISPR Editing Platform in 2023
3.3 CRISPR Editing Platform Company Evaluation Quadrant
3.4 CRISPR Editing Platform 麻豆原创: Overall Company Footprint Analysis
3.4.1 CRISPR Editing Platform 麻豆原创: Region Footprint
3.4.2 CRISPR Editing Platform 麻豆原创: Company Product Type Footprint
3.4.3 CRISPR Editing Platform 麻豆原创: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of 麻豆原创 Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 United States VS China VS Rest of the World (by Headquarter Location)
4.1 United States VS China: CRISPR Editing Platform Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: CRISPR Editing Platform 麻豆原创 Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: CRISPR Editing Platform Revenue 麻豆原创 Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: CRISPR Editing Platform Consumption Value Comparison
4.2.1 United States VS China: CRISPR Editing Platform Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: CRISPR Editing Platform Consumption Value 麻豆原创 Share Comparison (2019 & 2023 & 2030)
4.3 United States Based CRISPR Editing Platform Companies and 麻豆原创 Share, 2019-2024
4.3.1 United States Based CRISPR Editing Platform Companies, Headquarters (States, Country)
4.3.2 United States Based Companies CRISPR Editing Platform Revenue, (2019-2024)
4.4 China Based Companies CRISPR Editing Platform Revenue and 麻豆原创 Share, 2019-2024
4.4.1 China Based CRISPR Editing Platform Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies CRISPR Editing Platform Revenue, (2019-2024)
4.5 Rest of World Based CRISPR Editing Platform Companies and 麻豆原创 Share, 2019-2024
4.5.1 Rest of World Based CRISPR Editing Platform Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies CRISPR Editing Platform Revenue, (2019-2024)
5 麻豆原创 Analysis by Type
5.1 World CRISPR Editing Platform 麻豆原创 Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Animal Cell Editing Platform
5.2.2 Plant Cell Editing Platform
5.3 麻豆原创 Segment by Type
5.3.1 World CRISPR Editing Platform 麻豆原创 Size by Type (2019-2024)
5.3.2 World CRISPR Editing Platform 麻豆原创 Size by Type (2025-2030)
5.3.3 World CRISPR Editing Platform 麻豆原创 Size 麻豆原创 Share by Type (2019-2030)
6 麻豆原创 Analysis by Application
6.1 World CRISPR Editing Platform 麻豆原创 Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Gene/Genome Editing
6.2.2 Gene/Genome Screening
6.2.3 Other
6.3 麻豆原创 Segment by Application
6.3.1 World CRISPR Editing Platform 麻豆原创 Size by Application (2019-2024)
6.3.2 World CRISPR Editing Platform 麻豆原创 Size by Application (2025-2030)
6.3.3 World CRISPR Editing Platform 麻豆原创 Size by Application (2019-2030)
7 Company Profiles
7.1 Synthego
7.1.1 Synthego Details
7.1.2 Synthego Major Business
7.1.3 Synthego CRISPR Editing Platform Product and Services
7.1.4 Synthego CRISPR Editing Platform Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
7.1.5 Synthego Recent Developments/Updates
7.1.6 Synthego Competitive Strengths & Weaknesses
7.2 Repare Therapeutics
7.2.1 Repare Therapeutics Details
7.2.2 Repare Therapeutics Major Business
7.2.3 Repare Therapeutics CRISPR Editing Platform Product and Services
7.2.4 Repare Therapeutics CRISPR Editing Platform Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
7.2.5 Repare Therapeutics Recent Developments/Updates
7.2.6 Repare Therapeutics Competitive Strengths & Weaknesses
7.3 Crisprqc
7.3.1 Crisprqc Details
7.3.2 Crisprqc Major Business
7.3.3 Crisprqc CRISPR Editing Platform Product and Services
7.3.4 Crisprqc CRISPR Editing Platform Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
7.3.5 Crisprqc Recent Developments/Updates
7.3.6 Crisprqc Competitive Strengths & Weaknesses
7.4 Horizon
7.4.1 Horizon Details
7.4.2 Horizon Major Business
7.4.3 Horizon CRISPR Editing Platform Product and Services
7.4.4 Horizon CRISPR Editing Platform Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
7.4.5 Horizon Recent Developments/Updates
7.4.6 Horizon Competitive Strengths & Weaknesses
7.5 Crown Bioscience
7.5.1 Crown Bioscience Details
7.5.2 Crown Bioscience Major Business
7.5.3 Crown Bioscience CRISPR Editing Platform Product and Services
7.5.4 Crown Bioscience CRISPR Editing Platform Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
7.5.5 Crown Bioscience Recent Developments/Updates
7.5.6 Crown Bioscience Competitive Strengths & Weaknesses
7.6 Editas Medicine
7.6.1 Editas Medicine Details
7.6.2 Editas Medicine Major Business
7.6.3 Editas Medicine CRISPR Editing Platform Product and Services
7.6.4 Editas Medicine CRISPR Editing Platform Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
7.6.5 Editas Medicine Recent Developments/Updates
7.6.6 Editas Medicine Competitive Strengths & Weaknesses
7.7 Creative Biogene
7.7.1 Creative Biogene Details
7.7.2 Creative Biogene Major Business
7.7.3 Creative Biogene CRISPR Editing Platform Product and Services
7.7.4 Creative Biogene CRISPR Editing Platform Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
7.7.5 Creative Biogene Recent Developments/Updates
7.7.6 Creative Biogene Competitive Strengths & Weaknesses
7.8 Mammoth
7.8.1 Mammoth Details
7.8.2 Mammoth Major Business
7.8.3 Mammoth CRISPR Editing Platform Product and Services
7.8.4 Mammoth CRISPR Editing Platform Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
7.8.5 Mammoth Recent Developments/Updates
7.8.6 Mammoth Competitive Strengths & Weaknesses
7.9 Synbio Technologies
7.9.1 Synbio Technologies Details
7.9.2 Synbio Technologies Major Business
7.9.3 Synbio Technologies CRISPR Editing Platform Product and Services
7.9.4 Synbio Technologies CRISPR Editing Platform Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
7.9.5 Synbio Technologies Recent Developments/Updates
7.9.6 Synbio Technologies Competitive Strengths & Weaknesses
7.10 Abace Biology
7.10.1 Abace Biology Details
7.10.2 Abace Biology Major Business
7.10.3 Abace Biology CRISPR Editing Platform Product and Services
7.10.4 Abace Biology CRISPR Editing Platform Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
7.10.5 Abace Biology Recent Developments/Updates
7.10.6 Abace Biology Competitive Strengths & Weaknesses
7.11 BRL Medicine Inc
7.11.1 BRL Medicine Inc Details
7.11.2 BRL Medicine Inc Major Business
7.11.3 BRL Medicine Inc CRISPR Editing Platform Product and Services
7.11.4 BRL Medicine Inc CRISPR Editing Platform Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
7.11.5 BRL Medicine Inc Recent Developments/Updates
7.11.6 BRL Medicine Inc Competitive Strengths & Weaknesses
8 Industry Chain Analysis
8.1 CRISPR Editing Platform Industry Chain
8.2 CRISPR Editing Platform Upstream Analysis
8.3 CRISPR Editing Platform Midstream Analysis
8.4 CRISPR Editing Platform Downstream Analysis
9 Research Findings and Conclusion
10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

Companies Mentioned:

Synthego
Repare Therapeutics
Crisprqc
Horizon
Crown Bioscience
Editas Medicine
Creative Biogene
Mammoth
Synbio Technologies
Abace Biology
BRL Medicine Inc

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.